How to Get Wegovy Without Insurance in 2026
Wegovy's list price is $1,349 per month — but you almost never pay that. Below are the legitimate cash-pay paths that bring it down to roughly $249–$499/month in April 2026, ranked by typical cost.
Cash-pay Wegovy paths at a glance
| Path | Monthly | Annual |
|---|---|---|
| Wegovy savings card (with commercial insurance) | $0–$25 | $0–$300 |
| Compounded semaglutide via telehealth | $249 | $2,988 |
| NovoCare manufacturer self-pay | $499 | $5,988 |
| Branded Wegovy via telehealth | $449 | $5,388 |
| Cash retail (full WAC) | $1,349 | $16,188 |
1. Wegovy Savings Card (if you have commercial insurance)
If your commercial insurance already covers Wegovy, the manufacturer savings card from Novo Nordisk can drop your copay to as low as $0–$25 per month. This is by far the cheapest legitimate option, but it requires you to already have coverage. Apply directly at novocare.com.
Government insurance — Medicare, Medicaid, Tricare, VA — is excluded from manufacturer copay programs by federal anti-kickback rules.
2. Compounded semaglutide (~$249/mo, limited availability)
Compounded semaglutide is a personalized formulation made by a licensed 503A pharmacy. During the 2022–2024 FDA semaglutide shortage, this was the cheapest path. Since the FDA officially ended the shortage in 2024–2025, the regulatory basis for most compounded semaglutide has narrowed sharply.
As of April 2026, you can still find compounded semaglutide through some telehealth platforms (subject to state law and pharmacy availability), typically in the $249-per-month range. Verify the pharmacy is US-licensed and PCAB-accredited before ordering.
3. NovoCare manufacturer self-pay (~$499/mo)
NovoCare is Novo Nordisk's direct-to-patient program. It is the closest Wegovy equivalent of LillyDirect (which is for Eli Lilly drugs like Zepbound and Mounjaro). The NovoCare self-pay reference price for Wegovy is approximately $499 per month as of April 2026.
Eligibility is income-based and program details change. Apply at novocare.com.
Visit NovoCare →4. Branded Wegovy via telehealth (~$449/mo)
If NovoCare self-pay is not available to you, branded Wegovy through a telehealth platform typically runs around $449 per month and includes the prescriber visit and shipment. The trade-off vs NovoCare is the monthly subscription markup; the upside is faster onboarding (often 1–3 days to a prescription).
Major options as of April 2026:
- Hims & Hers — largest telehealth GLP-1 platform by revenue
- Ro — bundled Body Program with coaching
- Lemonaid Health — pay per visit, not subscription
- LifeMD — Novo Nordisk direct partnership
See our full telehealth provider comparison for side-by-side pricing, drug menu, and speed-to-Rx.
5. Switch to Zepbound (often cheaper per pound lost)
Zepbound (tirzepatide, made by Eli Lilly) reaches a higher peak weight loss in trial data — ~22.5% in SURMOUNT-1 vs Wegovy's ~14.9% in STEP-1 — and Eli Lilly's LillyDirect program offers self-pay vials for the lower doses starting around $349/month. For many cash-pay patients, Zepbound ends up cheaper per pound lost even though the monthly sticker can be similar.
Run the comparison directly on Wegovy vs Zepbound or use the cheapest GLP-1 finder to see your exact $/lb breakdown.
Bonus: oral Wegovy 25 mg (~$499/mo)
FDA-approved in early 2026, oral Wegovy 25 mg is the same molecule as the injection in tablet form. NovoCare self-pay pricing is the same as the injection (~$499/month). The downside is strict fasting requirements (empty stomach, 30-minute wait before food) and slightly lower trial efficacy (13.6% peak weight loss in OASIS-4 vs 14.9% in STEP-1). The upside is no needles.
Full details on the oral Wegovy page.
Frequently asked questions
How much does Wegovy cost without insurance in 2026?
The list price (Wholesale Acquisition Cost) is $1,349 per 28-day supply, but almost no one pays that without coverage. The realistic cash-pay floor in April 2026 is roughly $249–$499 per month depending on how you source it: NovoCare manufacturer self-pay, branded telehealth (Hims, Ro), or — when available — compounded semaglutide via licensed telehealth platforms.
What is NovoCare and how do I qualify?
NovoCare is Novo Nordisk's patient-assistance program for branded GLP-1s including Wegovy. The current NovoCare self-pay reference price is around $499 per month. Eligibility depends on income and insurance status; you apply through NovoCare directly. Even patients with commercial insurance can sometimes use the savings card to drop their copay to as little as $0, depending on plan rules.
Is the Wegovy savings card the same as NovoCare?
No — they are two different programs from Novo Nordisk. The Wegovy savings card is for patients whose commercial insurance already covers Wegovy and reduces the copay (often to $0–$25). NovoCare is the broader self-pay/patient-assistance pathway for patients without coverage. Government insurance (Medicare, Medicaid, Tricare, VA) is excluded from both programs by federal anti-kickback rules.
Is compounded semaglutide still available in 2026?
Limited. The FDA ended the official semaglutide drug shortage in 2024–2025, which removed the regulatory basis for most compounded semaglutide. Some 503A compounding pharmacies still produce personalized formulations on a case-by-case basis through licensed telehealth platforms, but availability is much narrower than during the 2023–2024 boom. Compounded tirzepatide (the molecule in Zepbound) remains in a gray area as of April 2026.
What about the new oral Wegovy 25 mg?
The FDA approved oral semaglutide 25 mg for chronic weight management in early 2026. It is the same molecule as injectable Wegovy in tablet form. NovoCare self-pay for the oral version starts around $499 per month — the same as the injection. The downside is strict fasting requirements (take on an empty stomach, no food for 30 minutes after) and a slightly lower trial efficacy (13.6% vs 14.9% peak weight loss).
Can I use a GoodRx coupon for Wegovy?
GoodRx coupons rarely beat NovoCare self-pay or telehealth pricing for Wegovy specifically, because Wegovy is a brand-name drug under patent and there is no generic. GoodRx is more useful for older GLP-1s with generic equivalents, or for the consultation cost (GoodRx Care subscription, $39/month, plus whatever the pharmacy charges).
Should I just switch to Zepbound or another GLP-1?
It is worth running the math. Zepbound (tirzepatide) has both higher trial efficacy (22.5% peak weight loss) and a lower self-pay floor through LillyDirect for some doses. If your insurance covers neither Wegovy nor Zepbound, you may end up paying less per pound lost on Zepbound. The /cheapest-glp1 and /compare/wegovy-vs-zepbound pages run those comparisons head to head.
Stay ahead of every GLP-1 development
We'll email you when something actually matters: new FDA approvals (Foundayo, CagriSema, retatrutide), pricing drops at LillyDirect/NovoCare, telehealth deals, clinical trial results, FDA recalls, and insurance policy changes. ~1-2 emails/month. No filler.